- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Snapshot for Amgen Inc (AMGN)
| Open: | 105.8900 | Day's Range: | 104.3300 - 106.0500 | Volume: | 3,037,993 |
|---|---|---|---|---|---|
| Previous Close: | 104.9700 | 52wk Range: | 67.6100 - 114.9500 | 1-Yr Rtn: | +55.58% |
Key Statistics for AMGN
| Current P/E Ratio (ttm) | 16.7136 |
|---|---|
| Estimated P/E(12/2013) | 14.5036 |
| Relative P/E vs. SPX | 1.0244 |
| Earnings Per Share (USD) (ttm) | 6.3200 |
| Est. EPS (USD) (12/2013) | 7.2830 |
| Est. PEG Ratio | 1.9830 |
| Market Cap (M USD) | 79,222.50 |
| Shares Outstanding (M) | 750.00 |
| 30 Day Average Volume | 3,996,972 |
| Price/Book (mrq) | 4.0624 |
| Price/Sale (ttm) | 4.6312 |
| Dividend Indicated Gross Yield | 1.78% |
| Cash Dividend (USD) | 0.4700 |
| Last Dividend | 05/14/2013 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/26/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for AMGN
Company Profile & Key Executives for AMGN
Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.
| Robert A Bradway "Bob"Chairman/President/CEO | Jonathan M PeacockExec VP/CFO |
| Anthony C Hooper "Tony"Exec VP:Commercial Ops | Madhavan BalachandranExec VP:Operations |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
AMGN News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page